Differences in care were most prominent when centers with a high proportion of minority patients were compared with the quality outcomes of white patients.
Feeds
38005 items (38005 unread) in 74 feeds
Acinar Cell Carcinoma
(254 unread)
Acinic Cell Carcinoma
(166 unread)
Adenoid Cystic Carcinoma
(817 unread)
Adrenal Gland Cancer
(3132 unread)
Ampulla Of Vater
(1030 unread)
Anal Cancer
(3884 unread)
Angiosarcoma
(1204 unread)
Appendix Cancer
(513 unread)
Bile Duct Cancer
(4609 unread)
Brain and CNS
(5045 unread)
Carcinoid
(1626 unread)
Endocrine/Neuroendocrine
(4250 unread)
Gall Bladder Cancer
(1710 unread)
Hemangioendothelioma
(439 unread)
Hepatoblastoma
(572 unread)
Pancreas
(513 unread)
Phyllodes
(296 unread)
PMP and Mucinous Tumors
(361 unread)
Rhabdomyosarcoma
(1388 unread)
Sarcoma
(6196 unread)
Google - Ampullary Cancer
-
Quality of End-of-Life Care Found to Be Worse at Cancer Centers Serving Minority Populations - Cancer Therapy Advisor
Posted: June 1st, 2019, 5:00am GMT
Quality of End-of-Life Care Found to Be Worse at Cancer Centers Serving Minority Populations Cancer Therapy Advisor